Close Menu
  • Home
  • Stock
  • Parenting
  • Personal
  • Fashion & Beauty
  • Finance & Business
  • Marketing
  • Health & Fitness
  • Tech & Gadgets
  • Travel & Adventure

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

Mount Everest: British mountaineer breaks climbing record for non-Nepali

mayo 18, 2025

‘It feels terrifying:’ Why some Americans are anxious about traveling abroad under Trump

mayo 18, 2025

Southeast Asia, Australia in Allianz’s M&A plans, CFO says

mayo 18, 2025
Facebook X (Twitter) Instagram
  • Home
  • Contact us
  • DMCA
  • Política de Privacidad
  • Publicidad en DD Noticias
  • Sobre Nosotros
  • Términos y Condiciones
Facebook X (Twitter) Instagram
DD Noticias: Tu fuente de inspiración diariaDD Noticias: Tu fuente de inspiración diaria
  • Home
  • Stock
  • Parenting
  • Personal
  • Fashion & Beauty
  • Finance & Business
  • Marketing
  • Health & Fitness
  • Tech & Gadgets
  • Travel & Adventure
DD Noticias: Tu fuente de inspiración diariaDD Noticias: Tu fuente de inspiración diaria
Home » 5 Things to Know Before the Stock Market Opens
Personal Development

5 Things to Know Before the Stock Market Opens

Jane AustenBy Jane Austenmarzo 10, 2025No hay comentarios3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


Davide Bonaldo / SOPA Images / LightRocket via Getty Images

Davide Bonaldo / SOPA Images / LightRocket via Getty Images

U.S. stock futures point lower after a volatile week of trading and President Donald Trump’s comments from a weekend interview in which he failed to rule out a recession; Oracle (ORCL) shares are declining ahead of the cloud services giant’s third-quarter earnings after the bell; Redfin (RDFN) shares soar 75% on news the digital real estate brokerage is being acquired by Rocket Companies (RKT) for $1.75 billion of equity value; and U.S.-listed shares of Novo Nordisk (NVO) are falling after the latest trial results of its CagriSema weight-loss drug. Here’s what investors need to know today.

U.S. stock futures are pointing lower after a week of volatile trading due to ongoing uncertainty about the impact of policies coming out of the White House and fears that the U.S. economy is headed toward a big slowdown. S&P 500 futures are down more than 1% after the index’s worst week since September. Nasdaq and Dow Jones Industrial Average futures are down by similar percentages. Yields on the 10-year Treasury note are lower at around 4.25% ahead of fresh inflation data this week. Gold futures are slipping. Oil futures are moving higher.

President Donald Trump this weekend dismissed business concerns over his tariffs policy on Canada, China, Mexico, and potentially other trading partners, saying the import taxes would bring «wealth back to America.» In a taped interview with Fox News, Trump didn’t rule out the possibility that disruptions from the tariffs could bring about an economic recession, arguing that their benefits to the economy could take «a little time.»

Oracle (ORCL) shares are down 1.5% in premarket trading ahead of its quarterly earnings report scheduled to be released after markets close today. The cloud services giant is projected by analysts tracked by Visible Alpha to report year-over-year revenue growth of 8% to $14.38 billion, and adjusted earnings per share (EPS) of $1.49, up nearly 6%. The company may also make commentary on its $500 billion Stargate joint venture to build artificial intelligence (AI) infrastructure.

Redfin (RDFN) shares are jumping 75% on news the digital real estate brokerage is being acquired by Rocket Companies (RKT) for $1.75 billion. Rocket shares are sinking 11% after the Detroit-based mortgage lender said it was buying Redfin in an all-stock transaction for $12.50 per share. «Together, we will improve the experience by connecting traditionally disparate steps of the search and financing process with leading technology that removes friction, reduces costs and increases value to American homebuyers,» Rocket Companies CEO Varun Krishna said.

Story Continues

Novo Nordisk’s (NVO) U.S.-listed shares are dropping 7% in premarket trading after Phase 3 trial results of its next-generation weight-loss treatment. The Danish drugmaker’s tests for CagriSema in patients with type 2 diabetes showed 15.7% average weight loss after 68 weeks, compared with 22.7% in a prior test. Both results were lower than Novo Nordisk’s 25% weight-loss goal for the drug.

Read the original article on Investopedia



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Jane Austen
  • Website

Related Posts

Buy, Sell, or Hold Post Q4 Earnings?

marzo 17, 2025

Buy, Sell, or Hold Post Q4 Earnings?

marzo 17, 2025

Buy, Sell, or Hold Post Q4 Earnings?

marzo 17, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Fast fashion pioneer Forever 21 files for bankruptcy — again

marzo 18, 2025

Dow gains 350 points as stocks climb for 2nd day after S&P 500 enters correction

marzo 18, 2025

Yellow Creditors Have Own Plan to Share Trucker’s $550 Million

marzo 18, 2025

Alphabet in Talks to Buy Startup Wiz for $30 Billion, WSJ Says

marzo 18, 2025
Top Reviews
DD Noticias: Tu fuente de inspiración diaria
Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
  • Home
  • Contact us
  • DMCA
  • Política de Privacidad
  • Publicidad en DD Noticias
  • Sobre Nosotros
  • Términos y Condiciones
© 2025 ddnoticias. Designed by ddnoticias.

Type above and press Enter to search. Press Esc to cancel.